HomeEIKN • NASDAQ
add
Eikon Therapeutics Inc
Previous close
$14.88
Day range
$13.85 - $15.36
Year range
$13.29 - $17.40
Market cap
779.18M USD
Avg Volume
387.30K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 67.78M | — |
Net income | -64.92M | — |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -64.00M | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 220.11M | — |
Total assets | 491.24M | — |
Total liabilities | 254.95M | — |
Total equity | 236.29M | — |
Shares outstanding | 2.87M | — |
Price to book | -0.07 | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -64.92M | — |
Cash from operations | -23.74M | — |
Cash from investing | 8.15M | — |
Cash from financing | 95.00K | — |
Net change in cash | -15.49M | — |
Free cash flow | — | — |
About
Founded
2019
Headquarters
Website
